机构：[1]Department of Thoracic Cancer, West China Hospital, Huaxi, Sichuan University, Chengdu, China,四川大学华西医院[2]Department of Medical Oncology, Cancer Centre Sun Yat-Sen University, Guangzhou, China,[3]Pulmonary Tumor Ward, Sichuan Cancer Hospital, Chengdu, China四川省肿瘤医院
第一作者机构：[1]Department of Thoracic Cancer, West China Hospital, Huaxi, Sichuan University, Chengdu, China,
推荐引用方式(GB/T 7714)：
Liu Y.,Zhang Y.,Zhang L.,et al.Efficacy of EGFR-TKIs for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports[J].JOURNAL OF THORACIC ONCOLOGY.2016,11(4):S130-S130.doi:10.1016/S1556-0864(16)30277-5.
APA：
Liu, Y.,Zhang, Y.,Zhang, L.,Liu, B.,Zhou, X....&Lu, Y..(2016).Efficacy of EGFR-TKIs for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports.JOURNAL OF THORACIC ONCOLOGY,11,(4)
MLA：
Liu, Y.,et al."Efficacy of EGFR-TKIs for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports".JOURNAL OF THORACIC ONCOLOGY 11..4(2016):S130-S130
医学